$ADAG
Adagene Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Jiangsu, China
ADAG chart
What traders are saying about $ADAG
Latest postsAdagene Inc. news
- Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
Yahoo Finance ·
- Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancer
marketbeat.com ·
- Adagene Inc. Estimates – NASDAQ:ADAG
TradingView ·
- Adagene Highlights SAFEbody Pipeline, ADG138 Clinical Launch and 2027 Catalysts
marketbeat.com ·
- Adagene to Participate in H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference
Yahoo Finance ·
- Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
Yahoo Finance ·
- Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
Yahoo Finance ·
- Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
Yahoo Finance ·
- Adagene to Participate in Three Upcoming Investor Conferences
Yahoo Finance ·
- Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
Yahoo Finance ·
- Adagene (ADAG) Upgraded to Buy: Here's What You Should Know
Yahoo Finance ·
- Are Medical Stocks Lagging Adagene (ADAG) This Year?
Yahoo Finance ·
Adagene Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.7M | $103,204 | $18.1M | $9.3M |
| Net income | -$17.6M | -$33.4M | -$18.9M | -$80.0M |
| Diluted EPS | $-0.30 | $-0.59 | $-0.35 | $-0.31 |
| Total assets (year end) | $78.3M | $89.3M | $115.7M | $152.4M |
| Cash and equivalents (year end) | $74.5M | $85.2M | $109.9M | $143.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adagene Inc.
- Ticker
- ADAG (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jiangsu, China
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1818838
Frequently asked questions
What exchange is Adagene Inc. listed on?
Adagene Inc. trades on the Nasdaq under the ticker symbol ADAG.
What industry is Adagene Inc. in?
Adagene Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Adagene Inc. headquartered?
Adagene Inc.'s business address on file with the SEC is in Jiangsu, China.
When does Adagene Inc.'s fiscal year end?
Adagene Inc.'s fiscal year ends on December 31.
How much revenue did Adagene Inc. report?
Adagene Inc. reported $7.7M in revenue for calendar year 2025, according to its SEC filings.